Evaluation of a Rapid Microbiological Method with a Mixed Culture Biofilm Model

References

1. 1.↵
   1. Miller M.J.

   1. Miller M. J.

   The Impact of Process Analytical Technology (PAT), cGMPS for the 21^st Century, and Other Regulatory and Compendial Initiatives on the Implementation of RMMs. In Encyclopedia of RMMs, Miller M.J., Ed.; DHI Publishing: Bethesda, MD, 2005; Vol. 1, pp 195–215.
2. 2.↵
   1. Miller M. J.

   RMMs and demonstrating a return on investment: It's easier than you think! Am. Pharm. Rev. 2009, 12 (5), 42–47.

   OpenUrl
3. 3.↵
   1. Miller M. J.

   1. Bierman C.

   Fact versus fiction: RMMs in the manufacturing environment. In Encyclopedia of RMMs, Miller M. J., Ed.; DHI Publishing: Bethesda, MD, 2005; Vol. 1, pp 105–121.

   OpenUrl
4. 4.↵
   PDA Technical Report 33. Evaluation, validation, and implementation of new microbiological testing methods. J. Parent. Sci. Technol. 2000, 54 (3).
5. 5.↵
   USP. Chapter 1223. Validation of Alternative Microbiological Methods. In United States Pharmacopeia; U.S. Pharmacopeial Convention: Rockville, MD, 2012; pp 873–875.
6. 6.↵
   Ph. Eur. Chapter 5.1.6. Alternative Methods for Control of Microbiological Quality. In European Pharmacopeia; Council of Europe: Strasburg, France, 2009; pp 532–543.
7. 7.↵
   1. Miller M. J.

   1. London R.,
   2. Schwedock J.,
   3. Sage A.,
   4. Michalek M.,
   5. Valley H.,
   6. Lacirigonla J.,
   7. Welter P.,
   8. Jimenez L.,
   9. Buhl S.,
   10. Straus D.

   The Growth Direct Test: A Rapid, Non-Destructive, Automated System for Microbial Enumeration. In Encyclopedia of RMMs, Miller M. J., Ed.; DHI Publishing: Bethesda, MD, 2005; Vol. 2, pp 103–135.

   OpenUrl
8. 8.↵
   1. Miller M. J.

   1. Ohresser S.

   ATP bioluminescence using Millipore's Milliflex® Rapid System. In Encyclopedia of RMMs, Miller M. J., Ed.; DHI Publishing: Bethesda, MD, 2005, Vol. 2, pp 137–174.

   OpenUrl
9. 9.↵
   1. Miller M. J.

   1. Yvon P.

   Viability-Based Technologies: Solid-Phase Cytometry Using Chemunex ScanRDI®. In Encyclopedia of RMMs, Miller M. J., Ed.; DHI Publishing: Bethesda, MD, 2005; Vol. 2, pp 291–315.

   OpenUrl
10. 10.↵
    1. Donlan R. W.,
    2. Costeron W. J.

    Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15 (2), 167–193.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Bridier A.,
    2. Briandet R.,
    3. Thomas V.,
    4. Dubois-Brissonnet F.

    Resistance of bacterial biofilms to disinfectants: a review. Biofouling 2011, 27 (9), 1017–1032.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Costerton J. W.,
    2. Lewandoski Z.,
    3. Caldwell D. E.,
    4. Korber D. R.,
    5. Lappin-Scott H. M.

    Microbial biofilms. Ann. Rev. Microbiol. 1995, 49, 711–745.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. McCormick K.

    Water for pharmaceutical uses. Quality 2002; Vol 2 (1), pp 193–217.

    OpenUrl
14. 14.↵
    1. Flemming H. C.,
    2. Geesey G. G.

    1. Mittelmann M. W.

    Bacterial Growth and Biofouling in Purified Water Systems. In Biofouling and Biocorrosion in Industrial Water Systems, Flemming H. C., Geesey G. G., Eds.; Springer-Verlag: Heidelberg, Germany, 1991; pp 133–154.
15. 15.↵
    Guide to Inspections of High Purity Water Systems. Retrieved April 5, 2013 from http://www.fda.gov/ICECI/Inspections/InspectionGuides/ucm074905.htm.
16. 16.↵
    1. Clontz L.,
    2. Wagner C. M.

    1. Fornalik M.

    Early Detection and Prevention of Biofilms in Process Equipment. In Biofilm Control in Drug Manufacturing, Clontz L., Wagner C. M., Eds.; DHI Publishing: Bethesda, MD, 2012; pp 333–372.
17. 17.↵
    1. Williams K. L.

    1. Haberer K.

    Terminal Sterilization and Parametric Release. In Microbial Contamination Control in Parenteral Manufacturing (Drugs and the Pharmaceutical Sciences); Williams K. L., Ed.; Marcel Dekker: New York, 2004; Vol. 140, pp 419–447.

    OpenUrl
18. 18.↵
    ISO 11989-8:2006/Amd 1:2011. Ophthalmic implants—intraocular lenses—Part 8: Fundamental requirements. Amendment 1.
19. 19.↵
    1. Bradshaw D. J.

    Metabolic responses in biofilms. Microbial Ecology in Health and Disease, 1995, 8, 313–316.

    OpenUrl
20. 20.↵
    1. Yao Y.,
    2. Sturdevant D. E.,
    3. Otto M.

    Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in the formation of biofilms. J. Infect. Dis. 2005, 191 (2), 289–298.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Shemesh M.,
    2. Tam A.,
    3. Steinberg D.

    Differential gene expression profiling of Streptococcus mutans cultured under biofilm and planktonic conditions. Microbiology 2007, 153 (Pt 5), 1307–1371.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    Guidance for Industry. Validation of growth-based rapid microbiological methods for sterility testing of cellular and gene therapy products. Center for Biologics Evaluation and Research, U.S. Food and Drug Aministration, 2008.
23. 23.↵
    1. Chavez de Paz L. E.,
    2. Hamilton I. R.,
    3. Svensäter G.

    Oral bacteria in biofilms exhibit slow reactivation from nutrient depletion. Microbiology 2008, 154 (Pt 7), 1927–1938.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Battin T. J.

    Assessment of fluorescein diacetate hydrolysis as a measure of total esterase activity in natural stream sediment biofilms. The Science of the Total Environment 1997, 198, 51–69.
25. 25.↵
    1. Shams A.,
    2. Rose L. J.,
    3. Hodges L.,
    4. Arduino. M. J.

    Survival of Burkholderia pseudomallei on environmental surfaces. Appl. Environ. Microbiol. 2007, 73 (24), 8001–8004.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. McBain A. J.

    Chapter 4. In Vitro Biofilm Models: An Overview. In Advances in Applied Microbiology; Academic Press New York, NY, 2009; Vol. 69, pp 99–131.
27. 27.↵
    1. Buckingham-Meyer K.,
    2. Goeres D. M.,
    3. Hamilton M. A.

    Comparative evaluation of biofilm disinfectant efficacy tests. J. Microbiol. Methods 2007, 70 (2), 236–244.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Florjanič M.,
    2. Kristl J.

    The control of biofilm formation by hydrodynamics of purified water in industrial distribution system. Int. J. Pharm. 2011, 405 (1–2), 16–22.

    OpenUrlPubMed
29. 29.↵
    1. Lau Y. L.,
    2. Liu D.

    Effect of flow rate on biofilm accumulation in open channels. Water Research 1993, 27 (3), 355–360.

    OpenUrl
30. 30.↵
    USP. Chapter 1231. Water for Pharmaceutical Purposes. United States Pharmacopeia, 35th ed.; U.S. Pharmacopeial Convention: Rockville, MD, 2012; p 5231.
31. 31.↵
    1. Niemira B. A.,
    2. Solomon E. B.

    Sensitivity of planktonic and biofilm-associated Salmonella spp. to ionizing radiation. Appl. Environ. Microbiol. 2005, 71 (5), 2732–2736.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Hammond A.,
    2. Dertien M. S.,
    3. Colmer-Hamood J. A.,
    4. Griswold J. A.,
    5. Hamood A. N.

    Serum inhibits P. aeruginosa biofilm formation on plastic surfaces and intravenous catheters. J. Surg. Res. 2010, 159 (2), 735–746.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Song B.,
    2. Leff L. G.

    Influence of magnesium ions on biofilm formation by Pseudomonas fluorescens. Microbiol. Res. 2006, 161 (4), 355–361.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Guggenheim M.,
    2. Thurnheer T.,
    3. Gmur R.,
    4. Giovanoli P.,
    5. Guggenheim B.

    Validation of the Zürich burn-biofilm model. Burns 2011, 37 (7), 1125–1133.

    OpenUrlCrossRefPubMed
35. 35.↵
    1. Costanzo S. P.,
    2. Borazjani R. N.,
    3. McCormick P. J.

    Validation of the ScanRDI for routine microbiological analysis of process water. PDA J. Pharm. Sci. Technol. 2002, 56 (4), 206–219.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Jones D. L.,
    2. Brailsford M. A.,
    3. Drocourt J.-L.

    Solid-phase laser-scanning cytometry: a new two-hour method for the enumeration of microorganisms in pharmaceutical water. Pharm. Forum 1999, 25 (1), 7626–7645.

    OpenUrl
37. 37.↵
    1. Jacobs A.,
    2. Chenia H. Y.

    Biofilm formation and adherence characteristics of Elizabethkingia meningoseptica isolate from Oreochromis mossambicus. Ann. Clin. Microbiol. Antimicrob. 2011, 10 (16); doi: 10.1186/1476-0711-10-16.
38. 38.↵
    1. Watts J. L.,
    2. Salmon S. A.,
    3. Yancey R. J.

    Use of modified Rambach agar to differentiate Streptococcus uberis from other mastitis streptococci. J. Dairy Sci. 1993, 76 (6), 1740–1743.

    OpenUrlPubMed
39. 39.↵
    ISO 21527-2:2009. Microbiology of food and animal feeding stuffs—Horizontal method for the enumeration of yeasts and moulds—Part 2: Colony count technique in products with water activity less than or equal to 0.95.
40. 40.↵
    USP. Chapter 1227. Validation of Microbial Recovery. United States Pharmacopeia; U.S. Pharmacopeial Convention: Rockville, MD, 2012; pp 883–884.
41. 41.↵
    1. Sutton S.

    Counting colonies. PMF Newsletter 2006, 12 (9). Retrieved April 09, 2013 from http://www.microbiologyforum.org/PMFNews/PMFNews.12.09.0609.pdf.
42. 42.↵
    1. Smith R.,
    2. Von Tress M.,
    3. Tubb C.,
    4. Vanhaecke E.

    Evaluation of the ScanRDI® as a rapid alternative to the pharmacopeial sterility test method: Comparison of the limits of detection. PDA J. Pharm. Sci. Technol. 2010, 64 (4), 356–363.

    OpenUrlAbstract/FREE Full Text
43. 43.↵
    1. Gilbert S. E.,
    2. Rose L. J.

    Survival and persistence of nonspore-forming biothreat agents in water. Lett. Appl. Microbiol. 2012, 55 (3), 189–194.

    OpenUrlPubMed
44. 44.↵
    1. Gapp G.,
    2. Guyomard S.,
    3. Nabel P.,
    4. Scouvart J.

    Evaluation of the applications of a system for real-time microbial analysis of pharmaceutical water systems. Eur. J. Parenteral Sci. 1999, 4 (4), 131–136.

    OpenUrl
45. 45.↵
    1. Miller M. J.

    1. McDaniel A.

    Validation of the ScanRDI® for microbial detection in mammalian cell culture systems. In Encyclopedia of RMMs, Miller M. J., Ed.; DHI Publishing: Bethesda, MD, 2005; Vol. 2, pp 339–356.

    OpenUrl
46. 46.↵
    1. Vanhee L. M. E.,
    2. Nelis H. J.,
    3. Coenye T.

    Enumeration of airborne bacteria and fungi using solid state cytometry. J. Microbiol. Methods 2008, 72 (1), 12–19.

    OpenUrlCrossRefPubMedWeb of Science
47. 47.↵
    1. Baudart J.,
    2. Coallier J.,
    3. Laurent P.,
    4. Prevost M.

    Rapid and sensitive enumeration of viable diluted cells of members of the family Enterobacteriaceae in freshwater and drinking water. Appl. Environ. Microbiol. 2002, 68 (10), 5057–5063.

    OpenUrlAbstract/FREE Full Text
48. 48.↵
    1. Parthuisot N.,
    2. Binet M.,
    3. Touron-Bodilis A.,
    4. Pougnard C.,
    5. Lebaron P.,
    6. Baudart J.

    Total and viable Legionella pneumophilia cells in hot and natural waters as measured by immunofluorescence-based assays and solid-phase cytometry. Appl. Environ. Microbiol. 2011, 77 (7), 6225–6232.

    OpenUrlAbstract/FREE Full Text
49. 49.↵
    1. Yu F. P.,
    2. Pyle B. H.,
    3. McFeters G. A.

    A direct viable count method for the enumeration of attached bacteria and assessment of biofilm disinfection. J. Microbiol. Methods 1993, 17 (3), 167–180.

    OpenUrlPubMed
50. 50.↵
    1. Pitts B.,
    2. Hamilton M. A.,
    3. Zelver N.,
    4. Stewart P. S.

    A microtiter-plate screening method for biofilm disinfection and removal. J. Microbiol. Methods 2003, 54 (2), 269–276.

    OpenUrlCrossRefPubMedWeb of Science
51. 51.↵
    1. Chavant P.,
    2. Gaillard-Martinie B.,
    3. Talon R.,
    4. Hebraud M.,
    5. Bernardi T.

    A new device for rapid evaluation of biofilm formation potential by bacteria. J. Microbiol. Methods 2007, 68 (3), 605–612.

    OpenUrlPubMed